GSK 206136
Alternative Names: GSK206136Latest Information Update: 18 Jul 2023
At a glance
- Originator GlaxoSmithKline
- Class Antidepressants; Anxiolytics
- Mechanism of Action Neurokinin 1 receptor antagonists; Serotonin uptake inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Anxiety disorders; Depressive disorders